Conditions: Metastatic Biliary Tract Carcinoma; Metastatic Colon Carcinoma; Metastatic Esophageal Carcinoma; Metastatic Malignant Digestive System Neoplasm; Metastatic Malignant Solid Neoplasm; Metastatic Pancreatic Carcinoma; Stage IV Colon Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Pemetrexed; Drug: PRMT5 Inhibitor BMS-986504
Sponsors: Northwestern University; National Cancer Institute (NCI)
Not yet **RECRUITING NOW**
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Pemetrexed; Drug: PRMT5 Inhibitor BMS-986504
Sponsors: Northwestern University; National Cancer Institute (NCI)
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
